EUCTR2005-002912-73-BE进行中（未招募）不适用
An Open Label Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of 15 mg Anecortave Acetate for Depot Suspension Combined with Verteporfin Therapy in Patients with Exudative Age-related Macular Degeneration and Retino-choroidal Anastomosis.
niversity Hospitals Leuven0 个研究点目标入组 20 人开始时间: 2005年8月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Clinical diagnosis of exudative AMD compicated with retino-choroidal anastomosis in the study eye (eye to be treated).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Use of any investigational drug or treatment related or unrelated to ARMD.
- •Patient on intravenous or subcutaneous anticoagulant therapy.
- •Patient with a clinically relevant medical condition or ophthalmic disease that may preclude safe participation in the study.
研究者
相似试验
进行中（未招募）
1 期
An Open Label Evaluation of the Safety and Efficacy of Basiliximab Maintenance in Ulcerative Colitis - BSX-002Steroid-refractory ulcerative colitisMedDRA version: 8.1 Level: LLT Classification code 10009900 Term: Colitis ulcerativeEUCTR2006-006319-54-GBCerimon Pharmaceuticals, Inc.135
进行中（未招募）
不适用
An Open Label Evaluation of the Safety and Efficacy of Basiliximab Maintenance in Ulcerative Colitis - BSX-002Steroid-refractory ulcerative colitisMedDRA version: 8.1Level: LLTClassification code 10009900Term: Colitis ulcerativeEUCTR2006-006319-54-BECerimon Pharmaceuticals, Inc.135
进行中（未招募）
1 期
An Open Label Evaluation of the Safety and Efficacy of Basiliximab Maintenance in Ulcerative Colitis - BSX-002Steroid-refractory ulcerative colitisMedDRA version: 8.1Level: LLTClassification code 10009900Term: Colitis ulcerativeEUCTR2006-006319-54-CZCerimon Pharmaceuticals, Inc.135
进行中（未招募）
1 期
An Open Label Evaluation of the Safety and Efficacy of Basiliximab Maintenance in Ulcerative Colitis - BSX-002Steroid-refractory ulcerative colitisMedDRA version: 8.1Level: LLTClassification code 10009900Term: Colitis ulcerativeEUCTR2006-006319-54-SKCerimon Pharmaceuticals, Inc.135
进行中（未招募）
1 期
Safety and Efficacy study assessing PRX 102 in Patients with Fabry Disease currently treated with REPLAGAL® (Agalsidase alfa)Fabry disease (a-galactosidase A deficiency)MedDRA version: 20.0Level: PTClassification code 10016016Term: Fabry's diseaseSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2016-001318-11-DEProtalix Ltd.22